MARKET PULSE-GT Advanced, Cytori, Endo Health, Immunogen, AOL
(For more market insights, including options activity, click on ; for the Day Ahead newsletter link.reuters.com/mex49s; the Morning Call newsletter, r.reuters.com/vut44v) U.S. stock index futures dipped on Tuesday ahead of data on the services sector, putting the S&P 500 on track to halt a two-day winning streak. S&P 500 futures were down 4.5 points, Dow Jones industrial average futures were down 47 points and Nasdaq 100 futures were down 9.25 points.
** GT ADVANCED TECHNOLOGIES INC, Monday close $8.38, up 24 pct premarket
** RUBICON TECHNOLOGY, Monday close $8.82, up 7 pct premarket
Apple Inc will open a manufacturing facility in Arizona in partnership with mineral crystal specialist GT Advanced Technologies to make sapphire materials for Apple's popular electronics devices.
Sapphire materials company Rubicon rose on news of the deal as it could benefit from higher demand in the industry.
** CYTORI THERAPEUTICS INC, Monday close $2.09, up 51 pct premarket
The medical device maker said on Monday it would receive up to $531 million from Chinese company Lorem Vascular as license fee for its stem cell therapy that removes fat cells from a patient's body. These cells, which are then injected into the affected area, increase blood profusion and heal the wound. Lorem will market the therapy in Asia-Pacific. Continued...